Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
03/05/2025
The exchange rate of New Taiwan Dollar against the US Dollar has fallen below 31 NT dollars, appreciating by over 1 NT dollar within the day, with an increase of over 3%, hitting a new high since January 2024.
Latest
2 m ago
Novo Nordisk: Wegovy, if approved, will be the first GLP-1 oral formulation for chronic weight management.
2 m ago
Novo Nordisk: Wegovy, if approved, will become the first GLP-1 oral formulation for chronic weight management.
6 m ago
Royal Bank of Canada: Maintain rating on Biogen (BIIB.US) from outperform to outperform, target price adjusted from $217.00 to $205.00.
8 m ago
Royal Bank of Canada: Maintains a rating for Bio-Rad Laboratories (BIO.US), adjusting from outperform to outperform rating, with a target price adjustment from $409.00 to $392.00.
9 m ago
Royal Bank of Canada: Maintain rating for Bicycle Therapeutics (BCYC.US), adjusting from outperform to outperform, target price adjusted from $35.00 to $32.00.
See all latest